Table 4.

Sensitivity/Specificity of the SDOC Criteria and Those of Other Published Criteria in Study Cohorts, %.

	LIFE-P		VIVE2		TOM		SECRET		PIE2		IDEA		Total
Sarcopenia Criteria	Sens.	Spec.	Sens.	Spec.	Sens.	Spec.	Sens.	Spec.	Sens.	Spec.	Sens.	Spec.	Sens.	Spec.
Men
SDOC
Grip Strength	71	61	72	38	95	31	50	79	-	94	-	85	78	50
Grip Strength/BMI	56	76	42	59	73	58	100	79	-	88	-	81	57	67
FNIH
Grip Strength	24	95	14	86	38	86	50	100	-	100	-	100	25	91
Grip Strength/BMI	53	79	26	73	73	68	100	79	-	88	-	89	50	75
EWGSOP	18	100	26	86	24	93	0	100	-	100	-	100	22	95
Women
SDOC
Grip Strength	46	66	50	68	-	-	30	89	75	89	75	83	48	80
Grip Strength/BMI	73	38	86	45	-	-	90	28	100	67	100	37	78	39
FNIH
Grip Strength	28	94	14	91	-	-	0	97	25	97	25	97	23	96
Grip Strength/BMI	32	87	36	91	-	-	30	89	75	89	75	83	36	87
EWGSOP	15	96	7	82	-	-	0	100	25	97	0	100	12	98

^*SDOC – Grip strength <35.5 and 20.0 kg in men and women, respectively; Grip/BMI <1.05 and <0.79 in men and women, respectively; FNIH Grip strength <26 and <16 kg in men and women, respectively; Grip/BMI <1.0 and <0.56 in men and women, respectively; EWGSOP based on low lean mass (ALM/ht² <7.23 and <5.67 kg/m² in men and women, respectively) plus low strength (grip strength <30 and <20 kg in men and women, respectively) and/or performance (gait speed <0.8 m/s).

IDEA = Intensive Diet and Exercise for Arthritis Study; LIFE-P = Lifestyle Interventions for the Elders Pilot Study; PIE2 = Pharmacologic Interventions in the Elders Study; SECRET = Study of the Effects of Calorie Restriction and Exercise Training; TOM = Testosterone in Older Men with Mobility Limitations Trial; VIVE2 = Vitality Independence and Vigor Study 2.